ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

AZN Astrazeneca Plc

12,020.00
-6.00 (-0.05%)
Last Updated: 10:42:57
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Astrazeneca Plc LSE:AZN London Ordinary Share GB0009895292 ORD SHS $0.25
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  -6.00 -0.05% 12,020.00 12,018.00 12,022.00 12,144.00 11,960.00 12,070.00 316,255 10:42:57
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Pharmaceutical Preparations 45.81B 5.96B 3.8415 31.22 185.93B
Astrazeneca Plc is listed in the Pharmaceutical Preparations sector of the London Stock Exchange with ticker AZN. The last closing price for Astrazeneca was 12,026p. Over the last year, Astrazeneca shares have traded in a share price range of 9,461.00p to 12,210.00p.

Astrazeneca currently has 1,550,189,338 shares in issue. The market capitalisation of Astrazeneca is £185.93 billion. Astrazeneca has a price to earnings ratio (PE ratio) of 31.22.

Astrazeneca Share Discussion Threads

Showing 2726 to 2746 of 6150 messages
Chat Pages: Latest  114  113  112  111  110  109  108  107  106  105  104  103  Older
DateSubjectAuthorDiscuss
08/6/2020
12:47
Someone commented to me that the global equity markets are rather like the roadrunner when he dashes over the cliff and his legs keep rotating before he finally realises he's in mid air and plummets to earth.Equities are something of a default option currently but valuations for many cyclicals are simply ignoring the fact that business is not going to bounce back to normal for many months if not years.A fund manager said to me many years ago that brokers are generally in the business of advising their customers to sell good performing quality stocks and switching into rather poor quality hazardous ones.I wonder why.
steeplejack
08/6/2020
11:56
S,
Tend to agree. UBS today reiterated it's Sell recommendation today. This is a near weekly occurance for the past month with a price target of £6! They certainly called that wrong, big time and these guys get paid!

Oilers starting to look overbought on a TA basis and AZN oversold so the sector rotation may reverse again?

beckers2008
08/6/2020
11:43
Incidentally,all the pharmaceuticals are down today from Glaxo to Smith & Nephew to Hikma.It suits the brokers to trigger further sector rotation.They'd like nothing better than to encourage sales of a big ticket stock like Astra Zeneca.
steeplejack
08/6/2020
11:17
I doubt it given what's been said but maybe AZN should put out a statement clarifying things.
steeplejack
08/6/2020
10:40
Analysts are always critical of capex on acquisitions however, their knowledge of the industry is rarely as key as that of the insiders!
ianood
08/6/2020
09:18
It's look like this deal may be on, bad move I think.
montyhedge
08/6/2020
08:23
From The Times :

Astrazeneca has abandoned a tentative interest in combining with an American rival Gilead Science, which is behind remdesivir, the coronavirus treatment.

hotfinance14
08/6/2020
07:39
The merger of Astra and Zeneca was made around the same time in 1999 and since then,the market cap of the combined group has ONLY doubled in dollar terms.I think it’s too early for Astra Zeneca to contemplate a further merger.Afterall,it’s only in last couple of years that shareholders have become convinced that rejecting the Pfizer bid was the correct course of action.i guess the Gilead speculation has been out there for awhile and has helped to depress the stock price as the market has concurrently moved towards cyclicals.
steeplejack
08/6/2020
06:54
Glaxo bought Smith Kline Beecham 22 years ago, shares surged to 23 pounds, 22 years later GSK shareprice below that day 22 years ago, so in 22 years no growth in shareprice and will be like it for the next 22 years. So not a good idea for Astra to bid for Gilead in my opinion.
montyhedge
07/6/2020
23:31
Down 3-5% tomorrow IMO- buying opportunity
smcni1968
07/6/2020
20:48
Depends on whether you have just bought or sold.
mac15
07/6/2020
20:35
Not a good idea.
montyhedge
07/6/2020
15:21
Technically AZN chart - BUY
high yields
07/6/2020
14:05
K,
PS has a strong investment track record whilst at the helm at AZ, he seems a smart cookie so I wouldn't be surprised to see the share price start to regain some momentum again?

beckers2008
07/6/2020
12:39
Any ideas what this will do to the share price on Mon -thanks
kylemichie1
05/6/2020
19:21
Positive comments from Prof Bell of Oxford regarding AZ and vaccine in interview on Channel 4 news tonight.
beckers2008
05/6/2020
13:31
B,

With Bill Gates comitting to AZ's vaccine with him and his Mrs 'hard earned' seems to me that there is some degree of validity in it.

Your timing may well be applauded?

beckers2008
05/6/2020
12:33
Sold Pennon to be fully invested here again, with more shares this time. Thought it had peaked for now at 93 quid and appears it had, but further downside from here looks limited.

Forgotten how stressful trying to second guess the market could be. Not recommended!

bluemango
05/6/2020
08:59
"is it safe to take aspirin to fight C19"

conflicting reports from WHO except that kids/teenagers
risk a life threatening condition called Reyes Syndrome
taking anti-inflammatory drugs
WebMD

mike24
05/6/2020
07:51
So the vaccine is already being manufactured. AZN will not make any profit from it but will share the financial risk. Its great to see a company being altruistic. If it works it will be a huge boost for the UK Oxford and the reputation of AZN.
amt
02/6/2020
21:51
Monty speak for i want in lower , the price has some way to go yet , upwards .
holts
Chat Pages: Latest  114  113  112  111  110  109  108  107  106  105  104  103  Older

Your Recent History

Delayed Upgrade Clock